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Genetic and Environmental Factors AssociatedWith the
Ganglion Cell Complex in a Healthy Aging British Cohort
Edward Bloch, MBBS; Ekaterina Yonova-Doing, MSc; Eneh Jones-Odeh, MBBS; Katie M.Williams, FRCOphth;
Diana Kozareva, BSc; Christopher J. Hammond, MD
IMPORTANCE Measurement of ganglion cell complex (GCC) thickness may bemore sensitive
than current methods for glaucoma diagnosis and research. However, little is known about
the factors influencing GCC thickness in the general population.
OBJECTIVES To investigate the heritability of and factors associated with GCC thickness in a
healthy aging population.
DESIGN, SETTING, AND PARTICIPANTS A cross-sectional twin studywas conducted from
August 27, 2014, to March 31, 2016, among 1657 participants of white British ancestry from
the TwinsUK study cohort without ocular pathologic conditions. Heritability analyses were
conducted in 1432 twins (426monozygous and 290 dizygous pairs). Association analyses
were performed using univariable andmultivariable stepwise linear regressionmodels, taking
family structure into account. Heritability analyses were conducted using maximum
likelihood structural equation twin modeling.
MAIN OUTCOMES ANDMEASURES Parametersmeasured included GCC thickness,
autorefraction, intraocular pressure, blood pressure, bodymass index, and cholesterol,
creatinine, glucose, insulin, triglycerides, and urea levels. Estimated glomerular filtration rate
was calculated using theModification of Diet in Renal Disease formula.
RESULTS Among the 1657 participants (mean [SD] age, 56.0 [15.3] years; 89.5%women and
10.5%men), the mean [SD] inner GCC thickness was 96.0 [7.6] μm (95% CI, 95.1-96.2). In
multivariable modeling, the mean inner GCC thickness was associated with advancing age
(β, –0.14; P < .001), increased bodymass index (β, –0.15; P = .001), spherical equivalent
(β, 0.70; P < .001), and higher estimated glomerular filtration rate (β, 0.03; P = .02). A 1-U
increase in age or bodymass index was associated with a 0.14-μm and 0.15-μm decrease in
GCC thickness, respectively (P < .001), while a 1-U increase in spherical equivalent or
estimated glomerular filtration rate was associated with a 0.70-μm (P < .001) and 0.03-μm
(P = .02) increase in GCC thickness, respectively. Ganglion cell complex thickness was not
associated with sex, intraocular pressure, or diabetes. Age-adjusted GCC thickness was highly
heritable, with additive genetic effects explaining 81% (95% CI, 78%-84%) of phenotypic
variance and individual environmental factors explaining the remaining 19% (95% CI,
16%-22%).
CONCLUSIONS AND RELEVANCE Ganglion cell complex thickness appears to be highly
heritable and further genetic analysis may help identify new biological pathways for
glaucoma. The results suggest it may be important to account for age, bodymass index,
refractive error, and sex when using GCC thickness as a diagnostic tool. Replication of their
results is required, as is further research to explain the association between renal function
and GCC thickness.
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G laucoma is the second leading cause of blindnessworldwide, affecting up to 3% of the global popula-tionolder than40years, and is forecasted toaffect 79.6
million people worldwide by 2020.1,2 Glaucoma comprises a
group of optic neuropathies characterized by progressive, ir-
reversible visual field loss. Impaired retrograde neurotrophic
transport causes dysfunction of retinal ganglion cells and, ul-
timately, apoptosis with axonal atrophy.3-5
As loss of retinal ganglion cells is not visible on ophthal-
moscopy, glaucoma is traditionallydetectedusingoptic nerve
examination and visual field tests. These tests have low sen-
sitivity,areproneto interobservervariation,anddetectchanges
that occur relatively late in the disease process, leading to a
diagnosticdelayofup to 10years.6-9Theadventof spectral do-
main-optical coherence tomography(SD-OCT)hasaffordedthe
opportunity toacquirenoninvasive invivohigh-resolutionseg-
mentationof the inner retinal layers.10-12 Since themacula con-
tains up to 50% of retinal ganglion cells, it is very sensitive to
early glaucomatousdamage.13 Spectral domain-optical coher-
ence tomographymeasurements of themacular ganglion cell
complex (GCC) thickness, comprising the ganglion cell layer,
the inner plexiform layer, and the retinal nerve fiber layer
(RNFL), correlate closelywith histologic data.14 Various stud-
ies have investigated the diagnostic ability and validity of
SD-OCT parameters, concluding that both GCC and peripap-
illary RNFL thickness have high sensitivity, specificity, and
positive predictive value for disease.15-27
It iswell established that older age andhigher intraocular
pressure (IOP) are risk factors for primary open-angle glau-
coma (POAG).28 It also has been suggested that factors such
as vascular dysregulation29-32 and diabetes33may play an im-
portant role in the development of POAG. In addition, family
history isknowntocontribute to the riskofdevelopingPOAG28
and genetic variants have been identified that play a role in
POAG and its endophenotypes.34,35
Theextent towhichanyof these factorsmay influenceGCC
thickness in a healthy population is unclear. We undertook a
cross-sectionalobservational studytoexplore thesystemicand
ophthalmicfactors influencingGCCthickness inahealthypopu-
lation of European ancestry. In particular,we focused onpara-
metersthatmightbeassociatedwithmicrovasculardamage,such
as blood pressure, diabetes, and renal function. To investigate
towhatextentgenetic factors influenceGCCthickness,weused
a twinmodel design to perform a heritability study.
Methods
Participants
Allmonozygousanddizygous twinpairswerevolunteers in the
TwinsUKstudy,anunselectedpopulation-basedtwincohortrep-
resentative of the broader population in terms of disease-
associated and lifestyle characteristics.36We assessed 1753 in-
dividuals for eligibility and included those of European ances-
try and who were 18 years or older and excluded 39 not of
Europeanancestry, 33with treatedglaucoma,4withocularhy-
pertension, 7 with other pathologic conditions affecting the
retina, 12withpoor-qualitySD-OCTimages,and1with incorrect
data.Zygositywasdeterminedbyastandardizedquestionnaire
and confirmed using genome-wide genotyping of single-
nucleotide polymorphisms or short tandem repeats in some
monozygous twin pairs forwhomgenome-wide datawere not
available.ThestudywasapprovedbytheGuy’sandSt.Thomas’
ethics committee and all the participants providedwritten in-
formedconsent inaccordancewiththeDeclarationofHelsinki.37
Clinical Examination
Data were collected between August 27, 2014, and March 31,
2016. Eachparticipant completed aquestionnaire to elicit any
previousophthalmichistory.Nonophthalmicparameterswere
assessed, including height, weight, blood pressure, and stan-
dard bloodmarkers relevant tomicrovascular disease (ie, lev-
elsofcholesterol, creatinine,glucose, insulin, triglycerides,and
urea). Estimated glomerular filtration rate (eGFR) was calcu-
latedusing theModificationofDiet inRenalDisease formula.38
Ophthalmic examination on both eyes included autore-
fraction, pachymetry, and noncontact measurement of IOP
(Visionix120;TheLuneauTechnologyGroup).Sphericalequiva-
lent (SphE) was calculated using the standard formula of
sphere + (cylinder/2). Fundus photography and SD-OCT,
including mapping of GCC thickness, were performed
(iVue SD-OCT; Optovue).18,19,39-41 Scans were reviewed by an
ophthalmologist (E.B.) and poor-quality scans (n = 59, con-
firmed by K.M.W.) were excluded from the final analyses. As
therewas a high correlation between left and right eyes for all
measurements (Pearsoncorrelationcoefficient, >0.7),weused
themean of the 2 eyes when both eyes were available.
Statistical Analysis
Differences betweenmonozygous and dizygous twins, or be-
tween any other group (eg, participantswith hypertension or
diabetes vs controls),were comparedusing2-sample, 2-tailed
t tests or z tests, assuming equal variance. Associations were
assessed between GCC thickness and the following 14 fac-
tors: age, sex, body mass index (BMI; calculated as weight in
kilograms divided by height inmeters squared), diabetes sta-
tus, bloodpressure (systolic anddiastolic), 2 ophthalmicpara-
meters (SphE and IOP), and 6 bloodmarkers (levels of choles-
terol, creatinine, glucose, insulin, triglycerides, and urea).
Key Points
Question What are the genetic and environmental factors
associated with ganglion cell complex thickness in a healthy aging
British cohort?
Findings In a cross-sectional twin cohort study of 1657
participants, ganglion cell complex thickness was associated with
age, bodymass index, and refractive error, as well as estimated
glomerular filtration rate. Ganglion cell complex thickness was
highly heritable, with additive genetic effects explaining 81% of
phenotypic variance.
Meaning Ganglion cell complex thickness appears to be a highly
heritable trait and adjustment for age, bodymass index, and
refractive error is important when using it as a diagnostic
parameter.
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Univariable linear regression analyses were performed, fol-
lowed by a multivariable linear regression model for factors
with an association significant at P < .05 in the univariable
model. Independent variableswere identified using stepwise
backwardprocedurewitha threshold for removal setatP < .05.
Variables that, in the multivariable model, would survive
Bonferroni correction for multiple testing (P ≤ .004; 0.05 di-
vided by 14,where 14 is the number of independent variables
tested),were consideredassociatedwithGCC thickness.Mean
arterial pressure and eGFR are not independent variables, as
they are calculated from these variables, so they donot affect
theBonferroni correction threshold. In all regressionmodels,
family structure was taken into account.
All analyses, except for the heritability, were carried out
using STATA, version 14, statistical package (StataCorp).Heri-
tability analyses were performed using maximum likelihood
structural equation twin modeling implemented in the
OpenMx package in R (http://openmx.psyc.virginia.edu). We
compared thephenotypic variancebetweenmonozygous and
dizygous twins to estimate the extent towhichGCC thickness
was a result of additive or dominant genetic effects and
commonoruniqueenvironmental factors. Thegoodnessof fit
of the full and reduced additive, common, and unique (ACE)
oradditive,dominant,andunique (ADE)modelswascompared
with theobserveddataandthebest-fittingmodelwasselected.
Before the heritability analysis, GCC thickness was adjusted
for age by linear regression of GCC and age and applying the
models to the residuals.
Results
Data on GCC thickness were acquired from 3235 eyes of 1657
predominantly female (89.5%) participants, whose demo-
graphic andclinical characteristics arepresented inTable 1.We
excluded 39 individuals of non-European ancestry, 44 with
ocular pathologic conditions, and 13 for other reasons. The in-
dividuals who were excluded for ocular pathologic condi-
tions or other reasonswere ameanof 14.3 years older than the
remainingparticipants,whowereamean (SD)ageof56.0 (15.3)
years (range, 18-90 years). Monozygous twins were on aver-
age younger than the dizygous twins (54 vs 59 years) and had
thickermeanGCC (96.4vs95.3μm;P = .01).Monozygous and
dizygous twins alsohaddifferentmean (SD) values for the fol-
lowingparameters:BMI (25.6 [0.16]vs26.5 [0.21]), SphE (–0.21
[0.08] vs 0.15 [0.10] diopters), systolic blood pressure (126.3
[0.58] vs 128.9 [0.66] mm Hg), and serum cholesterol level
(206.95 [1.54] vs 212.36 [1.54] mg/dL [to convert to milli-
moles per liter,multiply by0.0259]) (P ≤ .01 for all). After lin-
ear age adjustment, therewerenodifferencesbetweenmono-
zygous and dizygous twins for these variables.
The mean (SD) inner GCC thickness of the study popula-
tionwas96.0 (7.6) μm (95%CI, 95.1-96.2),withmean (SD) su-
perior thickness of 95.4 (7.7) μm (95% CI, 95.1-95.7) and infe-
rior thicknessof96.6 (8.0)μm(95%CI,96.2-96.8).Thesuperior
and inferior thicknesseswerehighly correlatedwith themean
inner GCC thickness (Pearson correlation coefficient, 0.97 for
both) and yielded similar results in all analyses.
Table 2 summarizes the results from the univariable and
multivariable stepwise regression analyses. On univariable
analysis, themeanGCCwas thinnerwithadvancingage (β [SE],
–0.12 [0.02]; P < .001), increased BMI (β [SE], –0.19 [0.04];
P < .001), andhigher systolic (β [SE], –0.06[0.01];P < .001)and
diastolic blood pressures (β [SE], –0.06 [0.02]; P = .003). The
association with systolic and diastolic blood pressure sur-
vivedadjustment forhypertension status (β [SE], –0.05 [0.01];
P < .001; andβ [SE], –0.04 [0.02];P = .02, respectively).Of the
ocular parameters, only SphEwas associatedwith GCC thick-
nessonunivariableanalysis (β [SE],0.45 [0.09];P < .001),with
a thinner GCC associated with a more myopic refraction. Re-
garding blood parameters, on univariable analysis GCC thick-
nesswasnegativelyassociatedwithan increase in levelsof cre-
atinine (β [SE], –2.69 [1.28]; P = .01), glucose (β [SE], –0.27
[0.003];P = .01), insulin (β [SE], –0.02 [0.01];P = .01), triglyc-
eride (β [SE], –0.01 [0.004]; P = .01), and urea (β [SE], –3.42
[0.90]; P < .001) levels (Table 2). In multivariable modeling,
themean inner GCC thickness was independently associated
withadvancingage (β [SE], –0.14 [0.02];P < .001), SphE(β [SE],
Table 1. Demographic and Clinical Characteristics of the Study Population
Characteristic Value
Age, mean (SD), y 56.0 (15.3)
Height, mean (SD), m
Women 1.6 (0.1)
Men 1.7 (0.1)
Weight, mean (SD), kg
Women 68.6 (13.2)
Men 82.6 (16.4)
Body mass index, mean (SD)a 26.2 (5.1)
Women 26.1 (4.9)
Men 27.3 (4.5)
Blood pressure, mean (SD), mm Hg
Systolic 127.3 (17.4)
Diastolic 75.8 (10.6)
Female sex, No. (%) 1483 (89.5)
Diabetes, No. (%) 190 (11.5)
Hypertension, No. (%) 290 (17.5)
Receiving antihypertensive treatment, No. (%) 213 (12.9)
IOP, mean (SD), mm Hg 13.3 (2.6)
SphE, mean (SD), diopters −0.1 (2.4)
CCT, mean (SD), μm 536.2 (35.6)
Total cholesterol, mean (SD), mg/dL 208.5 (42.5)
Creatinine, mean (SD), mg/dL 0.83 (0.15)
Glucose, mean (SD), mg/dL 86.5 (10.8)
Insulin, mean (SD), μIU/mL 49.1 (32.2)
Total triglycerides, mean (SD), mg/dL 88.5 (53.1)
Urea, mean (SD), mg/dL 32.43 (6.6)
Abbreviations: CCT, central corneal thickness; IOP, intraocular pressure;
SphE, spherical equivalent.
SI conversion factors: To convert cholesterol to millimoles per liter, multiply by
0.0259; creatinine to micromoles per liter, multiply by 88.4; glucose to
millimoles per liter, multiply by 0.0555; triglycerides to millimoles per liter,
multiply by 0.0113; and urea to micromoles per liter, multiply by 59.485.
a Calculated as weight in kilograms divided by height in meters squared.
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0.70 [0.09];P < .001), and increasedBMI (β [SE], –0.15 [0.04];
P = .001) only; these associationswould survive correction for
multiple testing (Bonferroni threshold, P ≤ .004).
Given thepossible connectionbetweenGCCthickness and
both blood pressure42-44 and kidney function,45 we explored
associated parameters even though they did not survive the
multivariable analysis.We first examined ifmeanarterial pres-
sure, which is considered to be a better marker of organ
perfusion,46 was associated with GCC thickness. The mean
arterial pressure in our study was a mean (SD) of 92.9
(12.1)mmHg. Similar to systolic and diastolic blood pressure,
mean arterial pressurewas associatedwithGCC thickness, ir-
respective of hypertension status (β, –0.06; P < .001), but not
when adjusted for age (β, –0.03; P = .13). Next, we looked at
whether GCC thickness was associated with the eGFR. In our
study, the mean (SD) eGFR was 82.5 (19.6) mL/min/1.73m2.
Higher eGFRwas associatedwith a thicker GCC, independent
of age, hypertension, and diabetes status (β, 0.03; P = .02).
Finally, we calculated the heritability of GCC thickness in
1432 twins (426monozygous and 290 dizygous pairs), as 225
individuals had their twinmissing. We found the best-fitting
model tobe theadditivegenetic anduniqueenvironment (AE)
model, in which 81% (95% CI, 78%-84%) of variance in age-
adjustedGCC thicknesswas explainedbyadditive genetic fac-
tors and the remaining 19% (95%CI, 16%-22%) by unique en-
vironmental factors.
Discussion
Many cross-sectional and longitudinal studies have investi-
gated the effects of age, sex, race/ethnicity, IOP, and axial
length on RNFL thickness.47-54 As GCC incorporates RNFL,
the 2 variables are correlated (Pearson correlation coeffi-
cient, 0.76 in this sample) and likely share risk factors. How-
ever, we set out to examine the associations in a large
population-based epidemiologic study of GCC thickness in
healthy European individuals and found it to be strongly and
independently associated with age, BMI, SphE, and eGFR.
Except for eGFR, all the other parameters survived correc-
tion for multiple testing.
With respect to age, our results are similar to those previ-
ously found forRNFL.55-57We found, cross-sectionally, a thin-
nerGCCwith older age (ameandecrease of 0.14 μmper year).
The effect we found is comparable with that found by Zhang
etal54 in92controls (0.17μmperyear) in theAdvancedImaging
forGlaucomaStudy. Incontrast, theassociationbetweenRNFL
andBMI ismore variable.Morbid obesity had a significant in-
fluence on RNFL, retinal ganglion cells, and choroidal thick-
ness in 1 study,58 while others suggest that BMI plays a role in
RNFL thickness only inmen55 or not at all.59 The UK Biobank
study founda significantnegative associationbetweenmacu-
lar thickness and both BMI and male sex,56 which is in keep-
ingwith our study findings of a reduction in GCC thickness of
0.15 μm per 1-U increase in BMI. Owing to the small number
of male participants in this study, we were underpowered to
detect sexeffects;however, thedirectionofeffectwas thesame
in the 2 groups (β, –0.19 andP < .001 forwomen; β, –0.28 and
P = .20 for men).
Studies of RNFL thickness from the European Prospec-
tive Investigation IntoCancerandNutrition (EPIC)-Norfolkand
UKBiobank cohorts foundRNFL andmacular thickness to be
thinner inmen than inwomen.55,56Wang et al60 foundno sex
differences in the mean thickness of GCC and ganglion cells
and the inner plexiform layer in a Chinese cohort. However,
while Mwanza et al61 did not find a difference between the
sexes formean thickness of ganglion cells and the inner plexi-
form layer (P = .36), they did find that male sex was associ-
ated with GCC thickness in multivariate analysis with RNFL
thickness, age, andaxial length (β, –1.62;P = .005).Wedidnot
observe a difference inmean (SD) GCC thickness between the
174 men (95.7 [7.98] μm) and 1483 women (96.1 [7.45] μm;
P = .69) in our study.
Of the ophthalmic parameters, GCC thickness was asso-
ciated only with SphE, withmoremyopic eyes having a thin-
ner GCC and amean increase in thickness of 0.70μmper 1-di-
opter increase in SphE. Previous studies have proposed that
longer axial length is associatedwith thinnerRNFL.62-64How-
ever, Khawaja et al,55 using scanning laser polarimetry in the
EPIC-Norfolk study, found that longer axial length appeared
to be associated with a thicker RNFL. There is some contro-
versy as to the possible magnification effects of the eye with
increasing ametropia, which is not routinely corrected for by
SD-OCT software.55,65,66 Some studies using SD-OCT have
found that this association reversed once ocular magnifica-
tion was mathematically corrected.65,67 Patel et al56 demon-
strated that, on results of SD-OCT, increasingmyopia was as-
sociated with increased central macular thickness but a
decrease in the other macular subfield thicknesses, resulting
in an overall positive association with refractive error. Opti-
cal coherence tomographyalsohas been shown tobemore re-
peatable and sensitive than glaucoma diagnoses by scanning
laser polarimetry at detecting glaucoma in cases of high
myopia.40,68-72 Irrespectiveofwhether theeffect isphysiologi-
cal or owing to optics, we propose that future studies of GCC
Table 2. Univariable andMultivariable Linear Regression Analysis
Characteristic
β (SE)
Univariable P Value Multivariable P Value
Age −0.12 (0.02) <.001 −0.14 (0.02) <.001
Sex 0.31 (0.77) .69
Body mass index −0.19 (0.04) <.001 −0.15 (0.04) .001
Blood pressure
Systolic −0.06 (0.01) <.001
Diastolic −0.06 (0.02) .003
Diabetes −0.91 (0.47) .05
Spherical equivalent 0.45 (0.09) <.001 0.70 (0.09) <.001
Intraocular pressure 0.05 (0.08) .51
Total cholesterol −0.01 (0.01) .27
Creatinine −2.69 (1.28) .01
Glucose −0.27 (0.03) .01
Insulin −0.02 (0.01) .01
Total triglycerides −0.01 (0.004) .01
Urea −3.42 (0.90) <.001
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should consider adjusting for SphEor axial length, given their
strong association with GCC thickness.
Although IOP is a known risk factor for POAG, we were
not able to identify an association between IOP and GCC
thickness in our study. However, this is in agreement with
the findings from RNFL association studies, such as the
EPIC-Norfolk, UK Biobank, and Advanced Imaging for Glau-
coma Study groups.54-56 It is possible that our exclusion of
individuals taking IOP-lowering medication diminished the
association with GCC thickness, although we excluded only
37 individuals on this criterion. Furthermore, there is
increasing evidence for the role of the association between
IOP and intracranial pressure, known as the translaminar
pressure difference, in the pathophysiologic cause of
glaucoma.73,74 It may be that the IOP does not damage reti-
nal ganglion cell axons at the lamina cribrosa until it reaches
a given threshold, which would, in part, further explain the
pathophysiologic cause of normal-tension glaucoma.
Vascular dysregulation has been proposed to play an im-
portant role in POAG29-32 and several recent studies have sug-
gested that systemichypertension is associatedwithRNFLand
GCC thinning, which may represent an important consider-
ationwhenusing retinal SD-OCTmeasurements as a diagnos-
tic tool.42-44 Therefore, in this study,we explored the associa-
tion between GCC thickness and blood pressure (systolic,
diastolic, and mean arterial pressure). We did find GCC to be
thinner in individuals with hypertension (94.3 μm) vs those
with normal blood pressure (96.3 μm; P < .001), and an in-
crease in any of the blood pressure parameters was associ-
atedwithGCCthickness inunivariable analyses.However, this
associationwas small (β, –0.06μm)andnot independent from
the effect of age.
Similarly, some studies have shown diabetes to have an
early neurodegenerative effect on the retina, causing neuro-
nal dysfunction, leading to thinning of both the RNFL and
GCC, with associated functional visual deficits.75-82
Chhablani et al79 showed that inner retinal thinning was
present in patients with type 2 diabetes, even before signs of
retinopathy were visible, while Salvi et al80 showed a signifi-
cant association of GCC thinning in patients with diabetic
polyneuropathy but not in those with retinopathy. We did
not find an association between a diagnosis of diabetes and
GCC thickness, nor with fasting serum glucose and insulin
levels. The participants in the TwinsUK study cohort are
generally healthy, so we may be underpowered to detect
effects specific to hypertension or diabetes, although our
study did include 290 and 190 participants with these
respective diagnoses.
Finally, we found eGFR to be associated with mean GCC
thickness. The association survived correction for the effects
of age, diabetes, and hypertension, accounting for a 0.03-μm
change in GCC thickness per 1-U change in eGFR. This find-
ing suggests that there may be an association between renal
function and retinal neuropathy. Srivastav et al83 found an
association between increased serum urea and creatinine
levels and decreased RNFL thickness in patients with diabe-
tes, while Shim et al84 recently demonstrated that low eGFR
levels are independently associated with POAG. However,
there is a paucity of data regarding this potential association
in the absence of diabetes. One study, by Demir et al,45
evaluated the RNFL thickness in patients with chronic renal
failure without diabetes, concluding that it was significantly
thinner than normal. Our data are consistent with this
notion, but further investigation is required to elucidate the
underlying association. It is accepted that the kidneys and
retina share common developmental pathways and struc-
tural similarities, such as the vascular configuration and
type IV collagen basement-membrane composition.85 There-
fore, if renal function correlates with retinal neuronal
anatomy in a healthy population, it may become a factor to
consider in the interpretation of GCC thickness as a diagnos-
tic parameter.
This is the first study, to our knowledge, that explores the
heritability of GCC thickness. We found GCC thickness to be
highly heritable, with additive genetic effects accounting for
81% of variance, while unique environmental effects ex-
plained the remaining 19% of variance. This finding is com-
parablewith theheritability estimates for central retinal thick-
ness (90%) andRNFL thickness (between48%and82%).86-88
It would be interesting to explore whether any of the known
genetic risk factors forPOAGand itsotherendophenotypesalso
influenceGCC thickness.Alleles inSIX1-SIX6 (GenBank: 6495
and4990, respectively)havebeenassociatedwithPOAG inge-
nome-wide association studies, andwith a decrease in global
and sectoral RNFL thickness in individuals of European and
Asian descent.89-91
Limitations
This studycontains some limitations.First, theTwinsUKstudy
cohort is predominantly females of European ancestry, limit-
ingourability todrawconclusionsas to theeffectof sexor race/
ethnicity on GCC thickness. As this is a cross-sectional study,
we cannot draw any conclusions on causation and, as an ob-
servational study, we are potentially susceptible to residual
confounding and missing data. As we relied on self-reported
ocular and systemic disease, as well as drug history, we may
be liable to misspecification of variables. Our novel findings
require replication.
Conclusions
Ganglion cell complex thickness is a highly heritable trait.We
identified anassociationbetweenSD-OCT–derivedGCC thick-
ness measurements and age, refractive error, BMI, and eGFR
in a healthy, aging, predominantly female cohort of Euro-
pean descent. The associations between SphE, BMI, and age
are strong and therefore adjustment is likely to be relevant if
GCC thicknesswere to be used as a clinical parameter. Future
studies of GCC and its association with glaucoma or neuro-
logic disease should take these associations into account.We
didnot findGCCthickness tobe independentlyassociatedwith
sex, diabetes, blood pressure, or IOP. Further studies are re-
quired toestablish theprecise associationbetween renal func-
tion and inner retinal structures and to investigate the ge-
netic factors underlying GCC thickness.
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